Compare Boston Scientific Corporation (BSX) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Star Bulk Carriers Corp — how do they compare? Boston Scientific Corporation trades at $43.37 (market cap $66.37B), while Star Bulk Carriers Corp trades at $26.22 (market cap $2.96B). The key difference: Boston Scientific Corporation is far larger — about 22.4× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.88% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | SBLK | |
|---|---|---|
Market Cap | $66.37B | $2.96B |
Sector | Health | Industrials |
52-Week High | $108.14 | $28.21 |
52-Week Low | $42.63 | $16.79 |
Enterprise Value | $75.94B | $3.66B |
Dividend Yield | — | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
Star Bulk Carriers (SBLK) trades at $26.54, up 0.72% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with Q1 2026 earnings beating expectations at $0.56 EPS versus $0.475 expected, while maintaining a healthy 13.01% net income margin. Recent news highlights robust dry bulk rates supporting potential double-digit dividend yields, with the company's modernizing fleet and opportunistic asset sales strengthening the balance sheet.
SBLK presents a compelling opportunity with strong cash flow generation and shareholder returns, though investors face risks from spot rate volatility and cyclical shipping demand. Wall Street maintains bullish sentiment with 14 buy ratings versus 2 sells, while technical indicators show potential resistance near $27 levels. The company's disciplined capital allocation and fleet renewal strategy provide upside potential if dry bulk markets remain favorable.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
